Healthcare service company Molina Healthcare Inc (NYSE:MOH) disclosed on Monday its net income of USD737m (USD11.47 per diluted share) for the year ended 31 December 2019.
This marks a growth when compared with net income of USD707m (USD10.61 per diluted share) for the year ended 31 December 2018.
Total revenues of USD16.83bn were generated in 2019, down over total revenues of USD18.8bn in 2018.
For the full year 2020, the company expects GAAP earnings per diluted share in the range of USD11.20 - USD11.70, as well as premium revenue growth of 7.4%. The guidance reflects the reintroduction of the Health Insurer Fee in 2020 with an impact of approximately USD0.30 per diluted share as well as currently exercising its protest rights on the new STAR+PLUS RFP award.
Advanz Pharma and Alvotech secure European approval for aflibercept biosimilar Mynzepli
Heron Therapeutics announces tax benefits preservation plan adoption
Essa Pharma sets ex-dividend date and due bill trading for USD80m capital return
BioDlink's bevacizumab injection secures Colombia and Pakistan marketing authorisation
GSK to receive USD370m and future royalties in CureVac/BioNTech settlement
Everest Medicines expands I-MAB investment
Perrigo Announces Quarterly Dividend
Ridgetech reports net income of USD10.20m in fiscal year 2025
Sanofi finalizes acquisition of Blueprint Medicines to expand rare disease and immunology portfolio
Perrigo to divest Dermacosmetics business for up to EUR327m
CVS Health declares quarterly dividend USD0.665 per share
Lilly declares dividend of USD1.50 for Q3
Bavarian Nordic sells US Priority Review Voucher for USD160m